Christophe Arbet-Engels
Chief Tech/Sci/R&D Officer chez X4 PHARMACEUTICALS, INC.
Profil
Christophe Arbet-Engels currently works at Harvard University, as Member-Biochemical Sciences Tutors Board and X4 Pharmaceuticals, Inc., as Chief Medical Officer from 2023.
Dr. Arbet-Engels also formerly worked at Biogen, Inc., as Vice President-Worldwide Medical, Poxel SA, as Chief Medical Officer & EVP-Medical Affairs from 2017 to 2019, Neurogastrx, Inc., as Chief Medical Officer from 2021 to 2023, and Millendo Therapeutics, Inc., as Chief Medical Officer from 2020 to 2021.
Dr. Arbet-Engels received his Masters Business Admin degree from Rutgers State University of New Jersey, graduate degree from Université de Paris XI Paris Sud, and doctorate degree from Université de Paris 5 René Descartes.
Postes actifs de Christophe Arbet-Engels
| Sociétés | Poste | Début |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2023 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Anciens postes connus de Christophe Arbet-Engels
| Sociétés | Poste | Fin |
|---|---|---|
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Chief Tech/Sci/R&D Officer | 01/08/2023 |
| MILLENDO THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| POXEL | Chief Tech/Sci/R&D Officer | 29/11/2019 |
| BIOGEN INC. | Corporate Officer/Principal | - |
Formation de Christophe Arbet-Engels
| Rutgers State University of New Jersey | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| POXEL | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Université de Paris XI Paris Sud | Consumer Services |
| Université de Paris 5 René Descartes | Consumer Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
